Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager

Molecular Therapy — Methods & Clinical Development(2025)10.1016/j.omtm.2025.101541Source: DataRank Database

Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager is a research paper published in Molecular Therapy — Methods & Clinical Development (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.70)OA: goldTopics (19)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

A. Reha,Brian Hutzen,Pin-Yi Wang ORCID,Chun‐Yu Chen ORCID,Andrea M. Glaspell ORCID

Live enrichment

PubMed:40799205 PMC:PMC12341704 OpenAlex:https://openalex.org/W4412629751

National Institutes of Health

Grant: 1R01CA278995-01A1

National Institutes of Health National Cancer Institute

Grant: P30 CA016058

National Institutes of Health National Cancer Institute

Grant: U54-CA232561

CancerFree KIDS

FWCI

2.70

Citation Percentile

0.9%

Citation Trend

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.omtm.2025.101541

publisherhttps://doi.org/10.1016/j.omtm.2025.101541

publisherhttps://api.elsevier.com/content/article/PII:S2329050125001366?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050125001366?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40799205

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchCytomegalovirus and herpesvirus research

Keywords

ImmunogenicityCD19VirologyTerm (time)T cellBiologyCellImmunologyImmune systemGeneticsPhysicsbiodistributiontoxicologyBispecific T Cell EngagerAdeno-associated Virus, AavB Cell Leukemia/Lymphoma

Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager

FAIR Checklist

Authors (18)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)